Works matching IS 11727047 AND DT 2010 AND VI 24 AND IP 1

Results: 10

Factors associated with serious adverse reactions to cholinesterase inhibitors: a study of spontaneous reporting.

Published in:

2010

By:

Pariente A;
Sanctussy DJ;
Miremont-Salamé G;
Moore N;
Haramburu F;
Fourrier-Réglat A;
L'Association Française des Centres Régionaux de Pharmacovigilance (CRPV);
Pariente, Antoine;
Sanctussy, Dina Joseph-Reinette;
Miremont-Salamé, Ghada;
Moore, Nicholas;
Haramburu, Françoise;
Fourrier-Réglat, Annie

Publication type:

journal article

Safety reporting and adverse-event profile of mirtazapine described in randomized controlled trials in comparison with other classes of antidepressants in the acute-phase treatment of adults with depression: systematic review and meta-analysis.

Published in:

2010

By:

Watanabe N;
Omori IM;
Nakagawa A;
Cipriani A;
Barbui C;
McGuire H;
Churchill R;
Furukawa TA;
MANGA (Meta-Analysis of New Generation Antidepressants) Study Group;
Watanabe, Norio;
Omori, Ichiro M;
Nakagawa, Atsuo;
Cipriani, Andrea;
Barbui, Corrado;
McGuire, Hugh;
Churchill, Rachel;
Furukawa, Toshi A

Publication type:

journal article

Role of brain-derived neurotrophic factor in the aetiology of depression: implications for pharmacological treatment.

Published in:

2010

By:

Castrén E;
Rantamäki T;
Castrén, Eero;
Rantamäki, Tomi

Publication type:

journal article

Spotlight on Atomoxetine in Attention-Deficit Hyperactivity Disorder in Children and Adolescents.

Published in:

CNS Drugs, 2010, v. 24, n. 1, p. 85, doi. 10.2165/11203670-000000000-00000

By:

Garnock-Jones, Karly P.;
Keating, Gillian M.

Publication type:

Article

Safety Reporting and Adverse-Event Profile of Mirtazapine Described in Randomized Controlled Trials in Comparison with Other Classes of Antidepressants in the Acute-Phase Treatment of Adults with Depression.

Published in:

CNS Drugs, 2010, v. 24, n. 1, p. 35, doi. 10.2165/11319480-000000000-00000

By:

Watanabe, Norio;
Omori, Ichiro M.;
Nakagawa, Atsuo;
Cipriani, Andrea;
Barbui, Corrado;
McGuire, Hugh;
Churchill, Rachel;
Furukawa, Toshi A.

Publication type:

Article

Role of Brain-Derived Neurotrophic Factor in the Aetiology of Depression.

Published in:

CNS Drugs, 2010, v. 24, n. 1, p. 1, doi. 10.2165/11530010-000000000-00000

By:

Castrén, Eero;
Rantamäki, Tomi

Publication type:

Article

Role of Antiepileptic Drugs as Preventive Agents for Migraine.

Published in:

CNS Drugs, 2010, v. 24, n. 1, p. 21, doi. 10.2165/11310970-000000000-00000

By:

Vikelis, Michail;
Rapoport, Alan M.

Publication type:

Article

Progress in Defining Optimal Treatment Outcome in Schizophrenia.

Published in:

CNS Drugs, 2010, v. 24, n. 1, p. 9, doi. 10.2165/11530250-000000000-00000

By:

Remington, Gary;
Foussias, George;
Agid, Ofer

Publication type:

Article

Factors Associated with Serious Adverse Reactions to Cholinesterase Inhibitors.

Published in:

CNS Drugs, 2010, v. 24, n. 1, p. 55, doi. 10.2165/11530300-000000000-00000

By:

Pariente, Antoine;
Joseph-Reinette Sanctussy, Dina;
Miremont-Salamé, Ghada;
Moore, Nicholas;
Haramburu, Françoise;
Fourrier-Réglat, Annie

Publication type:

Article

Blonanserin: A Review of its Use in the Management of Schizophrenia.

Published in:

CNS Drugs, 2010, v. 24, n. 1, p. 65, doi. 10.2165/11202620-000000000-00000

By:

Deeks, Emma D.;
Keating, Gillian M.

Publication type:

Article